{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:31:32Z","timestamp":1793309492853,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtauto.2024.100241","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T03:31:11Z","timestamp":1714102271000},"page":"100241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Stem cell-based therapy for systemic lupus erythematous"],"prefix":"10.1016","volume":"8","author":[{"given":"Maryam","family":"Zare Moghaddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Ghotloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6859","key":"10.1016\/j.jtauto.2024.100241_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jtauto.2024.100241_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41556-019-0344-z","article-title":"Advances in stem cell research and therapeutic development","volume":"21","author":"De Luca","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14653240903193806","article-title":"Mesenchymal stem cells in hematopoietic stem cell transplantation","volume":"11","author":"Battiwalla","year":"2009","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jbspin.2003.08.001","article-title":"Mesenchymal stem cells and rheumatoid arthritis","volume":"70","author":"Jorgensen","year":"2003","journal-title":"Joint Bone Spine"},{"issue":"5411","key":"10.1016\/j.jtauto.2024.100241_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00005-021-00603-y","article-title":"Functional characteristics and application of mesenchymal stem cells in systemic lupus erythematosus","volume":"69","author":"Tang","year":"2021","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jtauto.2024.100241_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2474-13-249","article-title":"The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system","volume":"13","author":"Wang","year":"2012","journal-title":"BMC Muscoskel. Disord."},{"issue":"174","key":"10.1016\/j.jtauto.2024.100241_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/3-540-31265-X_11","article-title":"Mesenchymal stem cells: isolation, in vitro expansion and characterization","author":"Beyer","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jtauto.2024.100241_bib10","article-title":"Mesenchymal stem cells migration homing and tracking","volume":"2013","author":"Sohni","year":"2013","journal-title":"Stem Cell. Int."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100241_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jtauto.2024.100241_bib12","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtauto.2024.100241_bib13","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","article-title":"Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide","volume":"101","author":"Krampera","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/stem.2254","article-title":"Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation","volume":"34","author":"Luz-Crawford","year":"2016","journal-title":"Stem Cell."},{"issue":"4","key":"10.1016\/j.jtauto.2024.100241_bib15","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.bbrc.2014.07.001","article-title":"MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6","volume":"450","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100241_bib16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib17","first-page":"2009","article-title":"Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells","volume":"18","author":"Yu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jtauto.2024.100241_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0076-6879(06)19007-2","article-title":"Hematopoietic stem cells","volume":"419","author":"Hawley","year":"2006","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jbm.a.20005","article-title":"Peripheral blood cell separation through surface-modified polyurethane membranes","volume":"68","author":"Higuchi","year":"2004","journal-title":"J. Biomed. Mater. Res."},{"issue":"11","key":"10.1016\/j.jtauto.2024.100241_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2024.100241_bib21","first-page":"105","article-title":"Hematopoietic stem cell transplantation","volume":"3","author":"Hatzimichael","year":"2010","journal-title":"Stem Cells Cloning"},{"key":"10.1016\/j.jtauto.2024.100241_bib22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2018.00646","volume":"9","author":"Pockley","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jtauto.2024.100241_bib23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/0961203317693096","article-title":"Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years","volume":"26","author":"Taraborelli","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2024.100241_bib24","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells' contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13287-019-1538-9","article-title":"Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib26","first-page":"109","article-title":"Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL\/lpr mice","volume":"6","author":"Zhang","year":"2014","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib27","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cell."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2249.2008.03683.x","article-title":"Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice","volume":"153","author":"Choi","year":"2008","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000513741","article-title":"An update for mesenchymal stem cell therapy in lupus nephritis","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Dis."},{"issue":"7","key":"10.1016\/j.jtauto.2024.100241_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.21037\/atm.2019.02.41","article-title":"Transplantation of dental tissue-derived mesenchymal stem cells ameliorates nephritis in lupus mice","volume":"7","author":"Tang","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/srep38237","article-title":"Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1\/Th2 ratios in a murine model of SLE","volume":"6","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep17685","article-title":"Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB\/W F1 mouse model of lupus nephritis","volume":"5","author":"Thiel","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3727\/096368910X520056","article-title":"Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis","volume":"20","author":"Chang","year":"2011","journal-title":"Cell Transplant."},{"issue":"8","key":"10.1016\/j.jtauto.2024.100241_bib34","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L","article-title":"Th1\/Th2 balance of peripheral T helper cells in systemic lupus erythematosus","volume":"42","author":"Akahoshi","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/art.33313","article-title":"Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation","volume":"64","author":"Choi","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2024.100241_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111256","article-title":"Mesenchymal stem cells attenuate systemic lupus erythematosus by inhibiting NLRP3 inflammasome activation through Pim-1 kinase","volume":"126","author":"Yu","year":"2024","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.2019050545","article-title":"Additive therapeutic effects of mesenchymal stem cells and IL-37 for systemic lupus erythematosus","volume":"31","author":"Xu","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.jtauto.2024.100241_bib38","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3727\/096368912X658692","article-title":"Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation","volume":"22","author":"Ma","year":"2013","journal-title":"Cell Transplant."},{"issue":"11","key":"10.1016\/j.jtauto.2024.100241_bib39","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3727\/096368914X685645","article-title":"Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus","volume":"24","author":"Park","year":"2015","journal-title":"Cell Transplant."},{"issue":"13","key":"10.1016\/j.jtauto.2024.100241_bib40","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/0961203310373782","article-title":"Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL\/lpr mice","volume":"19","author":"Gu","year":"2010","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jtauto.2024.100241_bib41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.stemcr.2018.01.029","article-title":"A long-term follow-up study of allogeneic mesenchymal stem\/stromal cell transplantation in patients with drug-resistant systemic lupus erythematosus","volume":"10","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"11","key":"10.1016\/j.jtauto.2024.100241_bib42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","article-title":"Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy","volume":"33","author":"Gu","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2024.100241_bib43","article-title":"Clinical efficacy and safety of mesenchymal stem cells for systemic lupus erythematosus","volume":"2020","author":"Zhou","year":"2020","journal-title":"Stem Cell. Int."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2478\/rir-2022-0011","article-title":"Stem cell therapy in lupus","volume":"3","author":"Yuan","year":"2022","journal-title":"Rheumatol. Immunol. Res."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000704","article-title":"Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE","volume":"9","author":"Kamen","year":"2022","journal-title":"Lupus Sci. Med."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib47","first-page":"1014","article-title":"[Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis]","volume":"50","author":"Liu","year":"2018","journal-title":"Beijing da xue xue bao Yi xue ban = J. Peking Uni. Health Sci."},{"issue":"12","key":"10.1016\/j.jtauto.2024.100241_bib48","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3727\/096368911X582769c","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 Years of experience","volume":"22","author":"Wang","year":"2013","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13287-018-0898-x","article-title":"Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus","volume":"9","author":"Zhu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"8","key":"10.1016\/j.jtauto.2024.100241_bib50","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2024.100241_bib51","article-title":"Immunomodulatory activity of mesenchymal stem cells in lupus nephritis: advances and applications","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2024.100241_bib52","first-page":"1","article-title":"A state-of-the-art review on the recent advances of mesenchymal stem cell therapeutic application in systematic lupus erythematosus","author":"Karimi","year":"2023","journal-title":"Immunol. Invest."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib53","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","article-title":"Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/cmi.2015.89","article-title":"The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"1 Pt 3","key":"10.1016\/j.jtauto.2024.100241_bib55","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jfma.2020.06.028","article-title":"MSCs-released TGF\u03b21 generate CD4(+)CD25(+)Foxp3(+) in T-reg cells of human SLE PBMC","volume":"120","author":"Darlan","year":"2021","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.jtauto.2024.100241_bib56","article-title":"Mesenchymal stem cell therapy: hope for patients with systemic lupus erythematosus","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jtauto.2024.100241_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/stcltm\/szad032","article-title":"Allogenic umbilical cord-derived mesenchymal stromal cells sustain long-term therapeutic efficacy compared with low-dose interleukin-2 in systemic lupus erythematosus","volume":"12","author":"Cao","year":"2023","journal-title":"Stem Cells Translat. Med."},{"key":"10.1016\/j.jtauto.2024.100241_bib58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ebiom.2019.06.016","article-title":"Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2","volume":"45","author":"Zhang","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2018.10.133","article-title":"Mesenchymal stem cells induced CD4+ T cell apoptosis in treatment of lupus mice","volume":"507","author":"Huang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.jtauto.2024.100241_bib60","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/0961203307084158","article-title":"Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients","volume":"16","author":"Dai","year":"2007","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib61","first-page":"351","article-title":"Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus","volume":"29","author":"Lashine","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"issue":"21","key":"10.1016\/j.jtauto.2024.100241_bib62","first-page":"4790","article-title":"Expression and clinical significance of miR-181a and miR-203 in systemic lupus erythematosus patients","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0961203319896417","article-title":"Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus","volume":"29","author":"Zheng","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2024.100241_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4174082","article-title":"Mesenchymal stem cells activate the MEK\/ERK signaling pathway and enhance DNA methylation via DNMT1 in PBMC from systemic lupus erythematosus","volume":"2020","author":"Xiong","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jtauto.2024.100241_bib65","article-title":"An overview of the safety, efficiency, and signal pathways of stem cell therapy for systemic lupus erythematosus","volume":"2021","author":"Yang","year":"2021","journal-title":"Stem Cell. Int."},{"issue":"4","key":"10.1016\/j.jtauto.2024.100241_bib66","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7861\/clinmedicine.18-4-329","article-title":"Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist","volume":"18","author":"Snowden","year":"2018","journal-title":"Clin. Med."},{"key":"10.1016\/j.jtauto.2024.100241_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-78580-6_1","article-title":"Principles and overview of allogeneic hematopoietic stem cell transplantation","volume":"144","author":"Giralt","year":"2009","journal-title":"Cancer Treat Res."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib68","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MOH.0000000000000531","article-title":"Application of stem cell transplantation in autoimmune diseases","volume":"26","author":"Ng","year":"2019","journal-title":"Curr. Opin. Hematol."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib69","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/wsbm.86","article-title":"Hematopoietic stem cell: self-renewal versus differentiation","volume":"2","author":"Seita","year":"2010","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.jtauto.2024.100241_bib70","series-title":"StemBook","article-title":"Egress and mobilization of hematopoietic stem and progenitor cells: a dynamic multi-facet process","author":"Lapid","year":"2008"},{"issue":"4","key":"10.1016\/j.jtauto.2024.100241_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jca.21329","article-title":"Peripheral stem cell collection: from leukocyte growth factor to removal of catheter","volume":"29","author":"Kindwall-Keller","year":"2014","journal-title":"J. Clin. Apher."},{"issue":"11","key":"10.1016\/j.jtauto.2024.100241_bib72","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2012-05-433755","article-title":"The function of hematopoietic stem cells is altered by both genetic and inflammatory factors in lupus mice","volume":"121","author":"Niu","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95224-y","article-title":"Patrolling human SLE haematopoietic progenitors demonstrate enhanced extramedullary colonisation; implications for peripheral tissue injury","volume":"11","author":"Kokkinopoulos","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib74","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/annrheumdis-2019-215782","article-title":"Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus","volume":"79","author":"Grigoriou","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib75","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2215\/CJN.10570918","article-title":"Autologous hematopoietic stem cell transplantation for refractory lupus nephritis","volume":"14","author":"Huang","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"issue":"3","key":"10.1016\/j.jtauto.2024.100241_bib76","first-page":"500","article-title":"Autologous peripheral blood haematopoietic stem cell transplantation for systemic lupus erythematosus: the observation of long-term outcomes in a Chinese centre","volume":"35","author":"Cao","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib77","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.transproceed.2011.03.039","article-title":"Autologous stem cell transplantation for systemic lupus erythematosus: report of efficacy and safety at 7 years of follow-up in 17 patients","volume":"43","author":"Song","year":"2011","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jtauto.2024.100241_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/380391","article-title":"Hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"2012","author":"Marmont du Haut Champ","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib79","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/096120339700600613","article-title":"Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration","volume":"6","author":"Marmont","year":"1997","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.jtauto.2024.100241_bib80","first-page":"494","article-title":"Good outcome of severe lupus patients with high-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation: a 10-year follow-up study","volume":"35","author":"Leng","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib81","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib82","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1378\/chest.127.5.1680","article-title":"Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation","volume":"127","author":"Traynor","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jtauto.2024.100241_bib83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry","volume":"22","author":"Alchi","year":"2013","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5114\/reum.2018.74750","article-title":"Quality of life in systemic lupus erythematosus and its measurement","volume":"56","author":"Olesi\u0144ska","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.jtauto.2024.100241_bib85","doi-asserted-by":"crossref","DOI":"10.1177\/2050312116671725","article-title":"SF-36 total score as a single measure of health-related quality of life: scoping review","volume":"4","author":"Lins","year":"2016","journal-title":"SAGE Open Med."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib86","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib87","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1705698","article-title":"Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission","volume":"40","author":"Loh","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.jtauto.2024.100241_bib89","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib90","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.TP.0000053198.99206.E6","article-title":"Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins","volume":"75","author":"Michallet","year":"2003","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jtauto.2024.100241_bib91","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1182\/blood.V91.7.2360","article-title":"Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins","volume":"91","author":"Genestier","year":"1998","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.jtauto.2024.100241_bib92","first-page":"1648","article-title":"[The variation of T-cell clonal repertoire in patients with systemic lupus erythematosus (SLE) following autologous peripheral blood hematopoietic stem cell transplantation]","volume":"83","author":"Fu","year":"2003","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"9231","key":"10.1016\/j.jtauto.2024.100241_bib93","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(00)02627-1","article-title":"Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study","volume":"356","author":"Traynor","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib94","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.retram.2016.03.004","article-title":"Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases","volume":"64","author":"Arruda","year":"2016","journal-title":"Curr Res. Transl. Med."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib95","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1191\/0961203304lu1027oa","article-title":"Autologous stem cell transplantation for systemic lupus erythematosus","volume":"13","author":"Jayne","year":"2004","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.jtauto.2024.100241_bib96","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib97","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41409-018-0173-x","article-title":"Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome","volume":"53","author":"Burt","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtauto.2024.100241_bib98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib99","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.autrev.2017.03.008","article-title":"Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: a systematic review","volume":"16","author":"Leone","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.jtauto.2024.100241_bib100","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2005-01-0330","article-title":"Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation","volume":"106","author":"Statkute","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib101","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.autrev.2017.03.008","article-title":"Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: a systematic review","volume":"16","author":"Leone","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.jtauto.2024.100241_bib102","first-page":"457","article-title":"Systemic lupus erythematosus and pregnancy","volume":"61","author":"Smyth","year":"2009","journal-title":"Minerva Urol. Nefrol."},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib103","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00296-010-1588-x","article-title":"Long-term remission after successful pregnancy in autologous peripheral blood stem cell transplanted system lupus erythematosus patients","volume":"31","author":"Meng","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1191\/0961203305lu2041cr","article-title":"Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus","volume":"14","author":"Talaulikar","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2024.100241_bib105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13223-019-0373-y","article-title":"Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review","volume":"15","author":"de Silva","year":"2019","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib106","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13223-019-0373-y","article-title":"Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review","volume":"15","author":"de Silva","year":"2019","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.jtauto.2024.100241_bib107","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/380391","article-title":"Hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"2012","author":"Marmont du Haut Champ","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"11","key":"10.1016\/j.jtauto.2024.100241_bib108","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/art.10594","article-title":"Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients","volume":"46","author":"Traynor","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib109","doi-asserted-by":"crossref","first-page":"4","DOI":"10.31138\/mjr.28.1.4","article-title":"Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies","volume":"28","author":"Adamichou","year":"2017","journal-title":"Mediterr J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2013-000004","article-title":"Value of repeat biopsy in lupus nephritis flares","volume":"1","author":"Greloni","year":"2014","journal-title":"Lupus Sci. Med."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib111","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1191\/0961203304lu491oa","article-title":"High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus","volume":"13","author":"Lisukov","year":"2004","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.jtauto.2024.100241_bib112","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib113","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41409-018-0173-x","article-title":"Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome","volume":"53","author":"Burt","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib114","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtauto.2024.100241_bib115","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.bbmt.2016.04.005","article-title":"Immune-Mediated complications after hematopoietic stem cell transplantation","volume":"22","author":"Li","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4 Pt 2","key":"10.1016\/j.jtauto.2024.100241_bib116","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/pr.2011.57","article-title":"Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases","volume":"71","author":"Daikeler","year":"2012","journal-title":"Pediatr. Res."},{"issue":"7","key":"10.1016\/j.jtauto.2024.100241_bib117","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/0961203316669242","article-title":"Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation","volume":"26","author":"Gladstone","year":"2017","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib118","doi-asserted-by":"crossref","first-page":"160","DOI":"10.15283\/ijsc17014","article-title":"Treatment with allogenic mesenchymal stromal cells in a murine model of systemic lupus erythematosus","volume":"10","author":"Tani","year":"2017","journal-title":"Int J Stem Cells"},{"issue":"6","key":"10.1016\/j.jtauto.2024.100241_bib119","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/TP.0000000000000975","article-title":"Allogeneic hematopoietic stem cell transplantation in the treatment of human C1q deficiency: the karolinska experience","volume":"100","author":"Olsson","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib120","first-page":"109","article-title":"Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL\/lpr mice","volume":"6","author":"Zhang","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.jtauto.2024.100241_bib121","article-title":"Xenogeneic transplantation of human placenta-derived mesenchymal stem cells alleviates renal injury and reduces inflammation in a mouse model of lupus nephritis","volume":"2019","author":"Liu","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jtauto.2024.100241_bib122","article-title":"Effect of human mesenchymal stem cells on xenogeneic T and B cells isolated from lupus-prone MRL<i&gt","volume":"2020","author":"Lee","year":"2020","journal-title":"Fas<\/i>lpr Mice. Stem Cells Int."},{"issue":"7","key":"10.1016\/j.jtauto.2024.100241_bib123","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/atm.2019.02.41","article-title":"Transplantation of dental tissue-derived mesenchymal stem cells ameliorates nephritis in lupus mice","volume":"7","author":"Tang","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jtauto.2024.100241_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/srep38237","article-title":"Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1\/Th2 ratios in a murine model of SLE","volume":"6","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2024.100241_bib125","doi-asserted-by":"crossref","first-page":"17685","DOI":"10.1038\/srep17685","article-title":"Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB\/W F1 mouse model of lupus nephritis","volume":"5","author":"Thiel","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib126","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3727\/096368910X520056","article-title":"Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis","volume":"20","author":"Chang","year":"2011","journal-title":"Cell Transplant."},{"issue":"1\u20134","key":"10.1016\/j.jtauto.2024.100241_bib127","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2018.10.133","article-title":"Mesenchymal stem cells induced CD4+ T cell apoptosis in treatment of lupus mice","volume":"507","author":"Huang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jtauto.2024.100241_bib128","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3389\/fimmu.2020.01912","article-title":"Immunomodulatory effects of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles in rheumatoid arthritis","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2024.100241_bib129","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","article-title":"Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2024.100241_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4174082","article-title":"Mesenchymal stem cells activate the MEK\/ERK signaling pathway and enhance DNA methylation via DNMT1 in PBMC from systemic lupus erythematosus","volume":"2020","author":"Xiong","year":"2020","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.jtauto.2024.100241_bib131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry","volume":"22","author":"Alchi","year":"2013","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.jtauto.2024.100241_bib132","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","article-title":"Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.jtauto.2024.100241_bib133","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2005-01-0330","article-title":"Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation","volume":"106","author":"Statkute","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtauto.2024.100241_bib134","doi-asserted-by":"crossref","first-page":"160","DOI":"10.15283\/ijsc17014","article-title":"Treatment with allogenic mesenchymal stromal cells in a murine model of systemic lupus erythematosus","volume":"10","author":"Tani","year":"2017","journal-title":"Int. J. Stem Cells"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902400011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258990902400011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T21:46:07Z","timestamp":1718574367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258990902400011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":134,"alternative-id":["S258990902400011X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100241","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell-based therapy for systemic lupus erythematous","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2024.100241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100241"}}